LSE - Delayed Quote GBp

Beximco Pharmaceuticals Limited (BXP.L)

Compare
30.00 -2.00 (-6.25%)
At close: October 22 at 4:08 PM GMT+1

Research Analysis

Revenue vs. Earnings

Revenue 10.99B
Earnings 1.36B
?

Analyst Price Targets

Earnings Estimate

CURRENCY IN USD Current Qtr. (Sep 2023)Next Qtr. (Dec 2023)Current Year (2023)Next Year (2024)
No. of Analysts ------1
Avg. Estimate 0008.14
Low Estimate 0008.14
High Estimate 0008.14
Year Ago EPS --------

Revenue Estimate

CURRENCY IN USD Current Qtr. (Sep 2023)Next Qtr. (Dec 2023)Current Year (2023)Next Year (2024)
No. of Analysts 2221
Avg. Estimate 256.91M256.91M256.91M294.38M
Low Estimate 252.86M252.86M252.86M294.38M
High Estimate 260.95M260.95M260.95M294.38M
Year Ago Sales ------256.91M
Sales Growth (year/est) ------14.60%

Earnings History

CURRENCY IN USD
EPS Est. --
EPS Actual --
Difference --
Surprise % --

EPS Trend

CURRENCY IN USD Current Qtr. (Sep 2023)Next Qtr. (Dec 2023)Current Year (2023)Next Year (2024)
Current Estimate 0008.14
7 Days Ago 0008.24
30 Days Ago 0008.24
60 Days Ago 0008.33
90 Days Ago 0008.36

EPS Revisions

CURRENCY IN USD Current Qtr. (Sep 2023)Next Qtr. (Dec 2023)Current Year (2023)Next Year (2024)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD BXP.LIndustrySectorS&P 500
Current Qtr. ------3.10%
Next Qtr. ------8.00%
Current Year ------2.30%
Next Year ------13.20%
Next 5 Years (per annum) ------11.85%
Past 5 Years (per annum) 2.32%------

Related Tickers